Taiwan Liposome Co., Ltd.
|Number of Estimates|
Taiwan Liposome Co., Ltd. engages in the authorized cooperative development of special medicine as well as new formulation and prescription drugs. The firm offers pain management, ophthalmology, and oncology related drugs based on lipid drug delivery system. It also provides royalties and biotechnology services. The company was founded by Chi Lung Hung on November 10, 1997 and is headquartered in Taipei, Taiwan.
Market Cap: 136 Million
Primary Exchange: NASDAQ
Shares Outstanding: 37 Million
Sector: Health Technology
Longest drawdown: 321 trading days
From: 2019-01-07 To: 2020-04-07
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|